ReviewVascular health and risk management2026
Refractory Kawasaki Disease in Infants Complicated with Giant Coronary Artery Aneurysms and Takayasu Arteritis: A Rare Case Report and Literature Review.
Review in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kawasaki disease (KD) is a common acute systemic vasculitis in children.10% to 20% of children present with refractory KD, and a few critically ill children may develop Kawasaki disease shock syndrome (KDSS) or macrophage activation syndrome (MAS). Coronary artery aneurysm (CAA) is the most serious complication of KD, and giant coronary artery aneurysm (GCAA) has an extremely poor prognosis. Takayasu arteritis (TAK) is a chronic granulomatous vasculitis mainly involving the aorta and its branches. It is extremely rare in infants, with no specific early symptoms and prone to delayed diagnosis. The combination of infant KD and TAK is extremely rare, as there is overlap in vascular involvement, making it difficult to differentiate clinically. This article reports the case of a 45-day-old male infant diagnosed with refractory KD, accompanied by KDSS and MAS. After conventional treatment, the condition relapsed and progressed to a GCAA, and subsequently TAK occurred. The complete clinical diagnosis and treatment process of the case will be elaborated in detail here. At the same time, based on the literature review, the diagnosis and treatment of this disease are analyzed to guide clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.